Cargando…
Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment
Ischemic heart disease and myocardial infarction remain leading causes of mortality worldwide. Existing myocardial infarction treatments are incapable of fully repairing and regenerating the infarcted myocardium. Stem cell transplantation therapy has demonstrated promising results in improving heart...
Autores principales: | Raziyeva, Kamila, Smagulova, Aiganym, Kim, Yevgeniy, Smagul, Saltanat, Nurkesh, Ayan, Saparov, Arman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582407/ https://www.ncbi.nlm.nih.gov/pubmed/33023264 http://dx.doi.org/10.3390/ijms21197301 |
Ejemplares similares
-
Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration
por: Smagul, Saltanat, et al.
Publicado: (2020) -
Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
por: Raziyeva, Kamila, et al.
Publicado: (2022) -
Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction
por: Kim, Yevgeniy, et al.
Publicado: (2021) -
Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
por: Sarsenova, Madina, et al.
Publicado: (2022) -
Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery
por: Berillo, Dmitriy, et al.
Publicado: (2021)